DOI:
10.1055/s-00000102
Zeitschrift für Palliativmedizin
LinksClose Window
References
Park K, Yu CJ, Kim SW. et al.
First-Line erlotinib therapy until and beyond response evaluation criteria in solid tumors progression in asian patients with epidermal growth factor receptor mutation-positive non-small-cell lung cancer: the ASPIRATION Study.
JAMA Oncol 2016;
2: 305-312
DOI: 10.1001/jamaoncol.2015.4921.
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.